Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Rank in Stocks
#4182
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Share Price
$2.29
Market Cap
$3.83B
Change (1 day)
3.06%
Change (1 year)
-6.38%
Country
CN
Trade Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Category
Healthcare
Revenue for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Revenue in Jun 2026 TTM: $1.14B
According to Shijiazhuang Yiling Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is $1.14B. In 2023 the company made a revenue of $1.46B a decrease compared to the revenue in the year 2022 that was $1.82B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Shijiazhuang Yiling Pharmaceutical Co., Ltd. from 2008 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $1.14B | 27.74% |
| 2024 | $892.27M | -38.79% |
| 2023 | $1.46B | -19.77% |
| 2022 | $1.82B | 14.15% |
| 2021 | $1.59B | 18.40% |
| 2020 | $1.34B | 60.70% |
| 2019 | $836.57M | 19.52% |
| 2018 | $699.93M | 11.58% |
| 2017 | $627.29M | 13.13% |
| 2016 | $554.46M | 13.06% |
| 2015 | $490.43M | 3.99% |
| 2014 | $471.61M | 14.88% |
| 2013 | $410.53M | 55.27% |
| 2012 | $264.39M | -14.67% |
| 2011 | $309.83M | 23.99% |
| 2010 | $249.88M | 4.51% |
| 2009 | $239.09M | 73.83% |
| 2008 | $137.55M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $2.54B | 122.50% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $830.81M | -27.11% |
US
|
|
| - | - |
IT
|
